Paraffin
As of the edition of 20 October 2026, Paraffin is a drug: marketed, first approved in 1966 (CH).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1966
- Kind
- Unknown
- Brand name
- Lansoyl
- First approved
- 9 June 1966 (CH)
- Approvals on record
- 2 in 1 region
- Holder of the most recent approval
- Almirall; 2 holders in all
- Registered trials
- 1, 0 stopped early
- Disease areas
- Immune system; Inherited and neonatal; Skin and connective tissue
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 3 | 1 | 1 | 0 | 0 |
| All trials | 1 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Almirall | Applicant | 1978 to now |